RE:RE:RE:RE:AstraZeneca's ADC disappoints - on severe adverse eventsDecember 13, 2023 - Pfizer CEO Albert Bourla plans to bring the “lightspeed principles” from Covid to other diseases, notwithstanding Pfizers disappointing performance in 2023.
https://endpts.com/pfizer-struggles-as-a-covid-boom-in-2022-evolves-into-one-of-markets-worst-drugmakers-in-2023/